Cefepime-Associated Myoclonic Seizures
- PMID: 31703011
- DOI: 10.1097/MJT.0000000000001106
Cefepime-Associated Myoclonic Seizures
Conflict of interest statement
The authors have no conflicts of interest to declare.
References
-
- Appa AA, Jain R, Rakita RM, et al. Characterizing cefepime neurotoxicity: a systematic review. Open Forum Infect Dis. 2017;4:ofx170.
-
- Lexicom, Cefepime Drug Information, Uptodate. Available at: http://www.uptodate.com. Accessed September 15, 2019.
-
- Sugimotoa M, Uchidaa I, Mashimo T, et al. Evidence for the involvement of GABAA receptor blockade in convulsions induced by cephalosporins. Neuropharmacology. 2003;45:304–314.
-
- Neu HC. Safety of cefepime: a new extended-spectrum parenteral cephalosporin. Am J Med. 1996;100(suppl 1):68S–75S.
-
- Lamoth F, Buclin T, Pascual A, et al. High cefepime plasma concentrations and neurological toxicity in febrile neutropenic patients with mild impairment of renal function. Antimicrob Agents Chemother. 2010;54:4360–4367.
LinkOut - more resources
Full Text Sources